GLP-1 Insurance Coverage Checker
Enter your insurance type and diagnosis, and we will tell you how likely it is that your plan covers Ozempic, Wegovy, Mounjaro, Zepbound, or other GLP-1 drugs. You will also see whether prior authorization is typically required and what documentation your doctor needs to submit.
Does my insurance cover Ozempic, Wegovy, or Mounjaro?
Coverage varies significantly by plan and indication. Most commercial plans and Medicare Part D cover GLP-1 medications for type 2 diabetes with prior authorization, but many exclude coverage for weight loss (obesity) indications. List prices range from $900-$1,500/month without insurance, though manufacturer savings cards can reduce costs to $25-$50/month for commercially insured patients. Enter your insurance type and diagnosis below for a personalized coverage estimate.
Key Facts
- $935–$1,430/mo — GLP-1 list prices without insurance
- 50%+ — employer plans now cover at least one GLP-1
- 2024 — Medicare began covering Wegovy for CV risk reduction
- $25–$150/mo — typical cost with manufacturer copay card
GLP-1 Medication Comparison
See how the major GLP-1 drugs stack up on weight loss, A1C reduction, and out-of-pocket cost.
Average Weight Loss (%)
Source: Clinical trial data (STEP, SURMOUNT, SUSTAIN trials)
A1C Reduction (percentage points)
Monthly List Price (USD)
Prices reflect manufacturer list price before insurance or copay cards.
Frequently Asked Questions
Does Medicare cover GLP-1 medications?
Medicare Part D covers GLP-1 medications prescribed for Type 2 Diabetes. In 2024, Wegovy gained coverage for cardiovascular risk reduction. Weight loss-only use is generally not covered by Medicare.
What is prior authorization?
Prior authorization means your doctor must get approval from your insurance before the medication is covered. This typically requires documentation of your diagnosis, BMI, and previous treatments tried.
What if my coverage is denied?
You have the right to appeal. Internal appeals succeed about 50% of the time. Include a letter of medical necessity from your prescriber and documentation of failed alternative treatments.
Are there savings programs?
Yes. Novo Nordisk (Ozempic/Wegovy) and Eli Lilly (Mounjaro/Zepbound) offer manufacturer savings cards that can reduce copays to $25-$150/month for eligible commercially insured patients.